Joseph P. Connor

Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical Cancers

Dohun Pyeon, Michael A. Newton, Paul F. Lambert et al. · Cancer Research · 2007 · 467 citations · Full text

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

Jennifer A. A. Gubbels, Jennifer A. Belisle, Masanori Onda et al. · Molecular Cancer · 2006 · 436 citations · Full text

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Maurie Markman, John A. Blessing, Stephen C. Rubin et al. · Gynecologic Oncology · 2005 · 243 citations

Phase Ii Trial, Medicine, Cancer Management +8

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

Jennifer A. Belisle, Sachi Horibata, Gubbels AA Jennifer et al. · Molecular Cancer · 2010 · 208 citations · Full text

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells

Jennifer A. A. Gubbels, Mildred Felder, Sachi Horibata et al. · Molecular Cancer · 2010 · 206 citations · Full text